| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antineoplastic Agents | 13 | 2019 | 803 | 2.950 |
Why?
|
| Tamoxifen | 6 | 2016 | 65 | 2.010 |
Why?
|
| Breast Neoplasms | 12 | 2020 | 1502 | 1.810 |
Why?
|
| Drug Design | 8 | 2017 | 162 | 1.410 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2015 | 33 | 1.350 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2016 | 222 | 1.350 |
Why?
|
| Selective Estrogen Receptor Modulators | 2 | 2020 | 32 | 1.260 |
Why?
|
| Prodrugs | 4 | 2015 | 24 | 1.220 |
Why?
|
| Neoplasms | 6 | 2019 | 1103 | 1.150 |
Why?
|
| Microsomes, Liver | 6 | 2013 | 70 | 0.960 |
Why?
|
| Estrogen Receptor alpha | 3 | 2020 | 111 | 0.900 |
Why?
|
| Proteomics | 6 | 2013 | 325 | 0.880 |
Why?
|
| Cell Line, Tumor | 14 | 2020 | 2231 | 0.860 |
Why?
|
| Estrogen Antagonists | 2 | 2013 | 28 | 0.820 |
Why?
|
| Morpholines | 3 | 2010 | 69 | 0.820 |
Why?
|
| Estrogens | 2 | 2013 | 202 | 0.730 |
Why?
|
| Receptors, Estrogen | 4 | 2014 | 156 | 0.650 |
Why?
|
| Structure-Activity Relationship | 8 | 2015 | 409 | 0.650 |
Why?
|
| Receptor, Cannabinoid, CB2 | 2 | 2010 | 32 | 0.640 |
Why?
|
| Immunotherapy | 1 | 2019 | 95 | 0.610 |
Why?
|
| Cell Proliferation | 8 | 2020 | 1198 | 0.600 |
Why?
|
| Thiazoles | 2 | 2015 | 74 | 0.600 |
Why?
|
| Sterols | 1 | 2016 | 23 | 0.570 |
Why?
|
| Boronic Acids | 1 | 2016 | 19 | 0.560 |
Why?
|
| Pyridines | 2 | 2014 | 116 | 0.560 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 119 | 0.540 |
Why?
|
| Nitrogen Mustard Compounds | 1 | 2015 | 1 | 0.530 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2015 | 17 | 0.530 |
Why?
|
| Anthraquinones | 1 | 2015 | 9 | 0.530 |
Why?
|
| Animals | 26 | 2020 | 15081 | 0.520 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 45 | 0.520 |
Why?
|
| Cell Movement | 3 | 2014 | 571 | 0.520 |
Why?
|
| Drug Discovery | 1 | 2015 | 82 | 0.500 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 37 | 0.500 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2020 | 259 | 0.490 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 56 | 0.490 |
Why?
|
| Bibenzyls | 1 | 2014 | 4 | 0.480 |
Why?
|
| Tubulin Modulators | 1 | 2014 | 18 | 0.480 |
Why?
|
| Indoles | 2 | 2006 | 158 | 0.470 |
Why?
|
| Isoflavones | 2 | 2014 | 129 | 0.460 |
Why?
|
| Tandem Mass Spectrometry | 7 | 2015 | 182 | 0.440 |
Why?
|
| Nitriles | 1 | 2013 | 69 | 0.440 |
Why?
|
| Mesoderm | 2 | 2013 | 70 | 0.440 |
Why?
|
| Triazoles | 1 | 2013 | 86 | 0.420 |
Why?
|
| Water Pollutants, Chemical | 2 | 2012 | 164 | 0.420 |
Why?
|
| Humans | 26 | 2020 | 37093 | 0.410 |
Why?
|
| Endocrine Disruptors | 1 | 2012 | 39 | 0.400 |
Why?
|
| Molecular Structure | 6 | 2015 | 492 | 0.380 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 2015 | 421 | 0.380 |
Why?
|
| Mice, Nude | 3 | 2020 | 337 | 0.370 |
Why?
|
| Polychlorinated Biphenyls | 2 | 2012 | 43 | 0.370 |
Why?
|
| Indomethacin | 1 | 2010 | 28 | 0.370 |
Why?
|
| Female | 18 | 2020 | 20969 | 0.350 |
Why?
|
| Pyrazoles | 2 | 2013 | 85 | 0.350 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2008 | 4 | 0.340 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2008 | 8 | 0.330 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2014 | 62 | 0.330 |
Why?
|
| Liver | 3 | 2017 | 479 | 0.330 |
Why?
|
| Signal Transduction | 6 | 2016 | 1908 | 0.330 |
Why?
|
| Epithelium | 1 | 2008 | 79 | 0.320 |
Why?
|
| Administration, Oral | 3 | 2020 | 224 | 0.320 |
Why?
|
| Mice | 9 | 2020 | 5913 | 0.310 |
Why?
|
| Receptors, Cannabinoid | 2 | 2004 | 26 | 0.300 |
Why?
|
| Water Pollutants | 1 | 2006 | 17 | 0.280 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 356 | 0.280 |
Why?
|
| Neoplasm Proteins | 3 | 2013 | 213 | 0.280 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2015 | 113 | 0.270 |
Why?
|
| Rivers | 1 | 2006 | 44 | 0.270 |
Why?
|
| Biological Availability | 2 | 2016 | 88 | 0.270 |
Why?
|
| Lung | 3 | 2014 | 446 | 0.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2013 | 807 | 0.260 |
Why?
|
| Pharmaceutical Preparations | 1 | 2006 | 75 | 0.260 |
Why?
|
| Piperidines | 1 | 2004 | 77 | 0.240 |
Why?
|
| Chick Embryo | 2 | 2014 | 74 | 0.240 |
Why?
|
| Curcumin | 2 | 2015 | 74 | 0.230 |
Why?
|
| Models, Animal | 2 | 2015 | 134 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 1609 | 0.230 |
Why?
|
| Tissue Scaffolds | 2 | 2014 | 25 | 0.220 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 251 | 0.220 |
Why?
|
| Naphthalenes | 1 | 2002 | 38 | 0.210 |
Why?
|
| Models, Molecular | 4 | 2015 | 808 | 0.210 |
Why?
|
| Rats | 8 | 2014 | 3483 | 0.210 |
Why?
|
| Receptors, Drug | 1 | 2002 | 58 | 0.210 |
Why?
|
| Down-Regulation | 2 | 2016 | 435 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1039 | 0.210 |
Why?
|
| Neoplastic Stem Cells | 2 | 2013 | 78 | 0.210 |
Why?
|
| Cannabinoids | 1 | 2002 | 56 | 0.200 |
Why?
|
| Proteome | 2 | 2013 | 144 | 0.200 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2012 | 78 | 0.190 |
Why?
|
| Geologic Sediments | 2 | 2012 | 42 | 0.180 |
Why?
|
| Chromatography, Liquid | 3 | 2013 | 142 | 0.160 |
Why?
|
| Blotting, Western | 2 | 2013 | 859 | 0.160 |
Why?
|
| Ligands | 2 | 2017 | 349 | 0.160 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2015 | 83 | 0.160 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2015 | 112 | 0.160 |
Why?
|
| Acetaminophen | 1 | 2018 | 27 | 0.160 |
Why?
|
| Enzyme Activation | 2 | 2017 | 444 | 0.160 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 27 | 0.160 |
Why?
|
| Arginine | 1 | 2018 | 73 | 0.150 |
Why?
|
| Cell Death | 2 | 2015 | 267 | 0.150 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2015 | 132 | 0.150 |
Why?
|
| Hela Cells | 2 | 2015 | 366 | 0.150 |
Why?
|
| Prostatic Neoplasms | 3 | 2015 | 935 | 0.150 |
Why?
|
| Hydroxides | 1 | 2016 | 7 | 0.140 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2017 | 59 | 0.140 |
Why?
|
| Nickel | 1 | 2016 | 20 | 0.140 |
Why?
|
| Vascular Diseases | 1 | 2017 | 30 | 0.140 |
Why?
|
| Aluminum | 1 | 2016 | 36 | 0.140 |
Why?
|
| Carbon Monoxide | 1 | 2016 | 34 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 33 | 0.140 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 71 | 0.140 |
Why?
|
| Stereoisomerism | 1 | 2016 | 167 | 0.140 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2016 | 40 | 0.130 |
Why?
|
| Pentanones | 1 | 2015 | 4 | 0.130 |
Why?
|
| Aminophenols | 1 | 2015 | 2 | 0.130 |
Why?
|
| Agaricales | 1 | 2015 | 6 | 0.130 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2015 | 28 | 0.130 |
Why?
|
| Estradiol | 3 | 2014 | 262 | 0.130 |
Why?
|
| Monophenol Monooxygenase | 1 | 2015 | 14 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2015 | 587 | 0.130 |
Why?
|
| Oxazines | 1 | 2015 | 26 | 0.130 |
Why?
|
| Tumor Burden | 1 | 2015 | 77 | 0.130 |
Why?
|
| Coumarins | 1 | 2015 | 38 | 0.130 |
Why?
|
| Genistein | 1 | 2015 | 42 | 0.120 |
Why?
|
| Adult Stem Cells | 1 | 2014 | 12 | 0.120 |
Why?
|
| Chorioallantoic Membrane | 1 | 2014 | 11 | 0.120 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2015 | 277 | 0.120 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 22 | 0.120 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 91 | 0.120 |
Why?
|
| Colchicine | 1 | 2014 | 15 | 0.120 |
Why?
|
| Cell-Free System | 1 | 2014 | 15 | 0.120 |
Why?
|
| Mass Spectrometry | 2 | 2006 | 260 | 0.120 |
Why?
|
| Proteoglycans | 1 | 2014 | 47 | 0.120 |
Why?
|
| Laminin | 1 | 2014 | 61 | 0.120 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 69 | 0.120 |
Why?
|
| Drug Combinations | 1 | 2014 | 98 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 59 | 0.120 |
Why?
|
| Glutarates | 1 | 2013 | 2 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 73 | 0.120 |
Why?
|
| Oximes | 1 | 2013 | 6 | 0.120 |
Why?
|
| Alphavirus | 1 | 2013 | 7 | 0.120 |
Why?
|
| Oxadiazoles | 1 | 2013 | 15 | 0.120 |
Why?
|
| Anopheles | 1 | 2013 | 17 | 0.120 |
Why?
|
| Tubulin | 1 | 2014 | 88 | 0.110 |
Why?
|
| Aromatase | 1 | 2013 | 19 | 0.110 |
Why?
|
| Receptors, Notch | 1 | 2013 | 33 | 0.110 |
Why?
|
| Collagen | 1 | 2014 | 172 | 0.110 |
Why?
|
| Aromatase Inhibitors | 1 | 2013 | 15 | 0.110 |
Why?
|
| Cell Shape | 1 | 2013 | 35 | 0.110 |
Why?
|
| rho-Associated Kinases | 1 | 2013 | 31 | 0.110 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 1371 | 0.110 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2013 | 30 | 0.110 |
Why?
|
| Vimentin | 1 | 2013 | 37 | 0.110 |
Why?
|
| Insect Proteins | 1 | 2013 | 50 | 0.110 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 75 | 0.110 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2013 | 25 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 219 | 0.110 |
Why?
|
| Taxoids | 1 | 2013 | 37 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2012 | 9 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2013 | 127 | 0.110 |
Why?
|
| Amides | 1 | 2013 | 68 | 0.110 |
Why?
|
| Regeneration | 1 | 2012 | 20 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 122 | 0.110 |
Why?
|
| Fundulidae | 1 | 2012 | 5 | 0.110 |
Why?
|
| Ethinyl Estradiol | 1 | 2012 | 9 | 0.110 |
Why?
|
| New Orleans | 1 | 2012 | 13 | 0.100 |
Why?
|
| Water Pollution, Chemical | 1 | 2012 | 10 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 312 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2013 | 80 | 0.100 |
Why?
|
| Specimen Handling | 1 | 2012 | 56 | 0.100 |
Why?
|
| Binding Sites | 1 | 2014 | 651 | 0.100 |
Why?
|
| Receptors, Leptin | 1 | 2012 | 13 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2014 | 305 | 0.100 |
Why?
|
| Macaca mulatta | 1 | 2012 | 128 | 0.100 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2012 | 19 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 2013 | 148 | 0.100 |
Why?
|
| Seawater | 1 | 2012 | 45 | 0.100 |
Why?
|
| Fresh Water | 1 | 2012 | 48 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2013 | 125 | 0.100 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 103 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2012 | 153 | 0.100 |
Why?
|
| Cell Division | 1 | 2012 | 307 | 0.100 |
Why?
|
| Mississippi | 1 | 2012 | 122 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 90 | 0.100 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 43 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 76 | 0.100 |
Why?
|
| Pesticides | 1 | 2012 | 52 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 88 | 0.100 |
Why?
|
| Phenols | 1 | 2012 | 80 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 623 | 0.100 |
Why?
|
| Disease Progression | 1 | 2013 | 601 | 0.100 |
Why?
|
| Leptin | 1 | 2012 | 118 | 0.090 |
Why?
|
| Response Elements | 1 | 2010 | 56 | 0.090 |
Why?
|
| Louisiana | 2 | 2008 | 43 | 0.090 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2010 | 98 | 0.090 |
Why?
|
| Receptors, Progesterone | 1 | 2010 | 81 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 626 | 0.090 |
Why?
|
| Environmental Monitoring | 2 | 2012 | 192 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2015 | 289 | 0.090 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2008 | 21 | 0.080 |
Why?
|
| Oryzias | 1 | 2008 | 9 | 0.080 |
Why?
|
| Apoptosis | 2 | 2013 | 1398 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 358 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 189 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2012 | 1207 | 0.080 |
Why?
|
| Benzamidines | 1 | 2007 | 5 | 0.080 |
Why?
|
| Trypanosoma brucei rhodesiense | 1 | 2007 | 6 | 0.080 |
Why?
|
| Soil Pollutants | 1 | 2008 | 87 | 0.080 |
Why?
|
| Trypanosomiasis, African | 1 | 2007 | 23 | 0.080 |
Why?
|
| Cyclonic Storms | 1 | 2008 | 64 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 578 | 0.070 |
Why?
|
| Trypanocidal Agents | 1 | 2007 | 39 | 0.070 |
Why?
|
| Piperazines | 1 | 2007 | 111 | 0.070 |
Why?
|
| Hypochlorous Acid | 1 | 2006 | 3 | 0.070 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2006 | 13 | 0.070 |
Why?
|
| Secretory Vesicles | 1 | 2006 | 20 | 0.070 |
Why?
|
| Cystic Fibrosis | 1 | 2006 | 18 | 0.070 |
Why?
|
| Phagosomes | 1 | 2006 | 30 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 409 | 0.070 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2007 | 83 | 0.070 |
Why?
|
| Phenotype | 1 | 2008 | 689 | 0.070 |
Why?
|
| Oxocins | 1 | 2005 | 3 | 0.070 |
Why?
|
| Marine Toxins | 1 | 2005 | 13 | 0.070 |
Why?
|
| Neutrophils | 1 | 2006 | 131 | 0.070 |
Why?
|
| Cell Survival | 1 | 2008 | 864 | 0.070 |
Why?
|
| Hepatocytes | 1 | 2005 | 75 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 562 | 0.060 |
Why?
|
| Kinetics | 2 | 2015 | 708 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 935 | 0.060 |
Why?
|
| Benzoxazines | 1 | 2002 | 46 | 0.050 |
Why?
|
| Extracellular Matrix | 2 | 2014 | 115 | 0.050 |
Why?
|
| Male | 6 | 2015 | 20025 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2014 | 1518 | 0.040 |
Why?
|
| Tablets | 1 | 2018 | 9 | 0.040 |
Why?
|
| Electrodes | 1 | 2018 | 45 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 2018 | 132 | 0.040 |
Why?
|
| Surface Properties | 1 | 2018 | 130 | 0.040 |
Why?
|
| Graphite | 1 | 2018 | 51 | 0.040 |
Why?
|
| Electrochemical Techniques | 1 | 2016 | 22 | 0.040 |
Why?
|
| Adsorption | 1 | 2016 | 68 | 0.040 |
Why?
|
| Catalysis | 1 | 2016 | 179 | 0.030 |
Why?
|
| Nanotubes, Carbon | 1 | 2016 | 79 | 0.030 |
Why?
|
| Cyclization | 1 | 2015 | 48 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 120 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2015 | 48 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2015 | 92 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 306 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2015 | 207 | 0.030 |
Why?
|
| Phytoestrogens | 1 | 2014 | 38 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2014 | 50 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2014 | 35 | 0.030 |
Why?
|
| Osteoporosis | 1 | 2014 | 34 | 0.030 |
Why?
|
| Bioartificial Organs | 1 | 2014 | 2 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 81 | 0.030 |
Why?
|
| Models, Chemical | 1 | 2015 | 207 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 502 | 0.030 |
Why?
|
| Oxygen | 1 | 2015 | 207 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 103 | 0.030 |
Why?
|
| Equipment Design | 1 | 2014 | 124 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 431 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2014 | 60 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 61 | 0.030 |
Why?
|
| Fixatives | 1 | 2012 | 7 | 0.030 |
Why?
|
| Deoxycholic Acid | 1 | 2012 | 10 | 0.030 |
Why?
|
| Perfusion | 1 | 2012 | 33 | 0.030 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2012 | 9 | 0.030 |
Why?
|
| Detergents | 1 | 2012 | 24 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2012 | 22 | 0.030 |
Why?
|
| Deoxyribonucleases | 1 | 2012 | 25 | 0.030 |
Why?
|
| Gills | 1 | 2012 | 11 | 0.030 |
Why?
|
| Prostate | 1 | 2014 | 154 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2012 | 48 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2012 | 67 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2012 | 212 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 109 | 0.020 |
Why?
|
| Lipids | 1 | 2013 | 235 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 182 | 0.020 |
Why?
|
| Nanostructures | 1 | 2013 | 134 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 661 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 302 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2012 | 150 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 282 | 0.020 |
Why?
|
| DNA | 1 | 2012 | 574 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 1180 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1618 | 0.020 |
Why?
|
| Mutagenicity Tests | 1 | 2008 | 21 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 972 | 0.020 |
Why?
|
| Parasitic Sensitivity Tests | 1 | 2007 | 14 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2007 | 99 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2006 | 32 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2006 | 69 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2006 | 57 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2005 | 99 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2005 | 167 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 173 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2006 | 513 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2006 | 540 | 0.010 |
Why?
|